An overview of current phase 3 radiopharmaceutical therapy clinical trials

  • 12:14
Ver Detalles

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia

  • 14:48
Ver Detalles

Radiopharmaceuticals and their applications in medicine

  • 13:56
Ver Detalles

Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I

  • 18:58
Ver Detalles

Alpha Atlas: Mapping global production of alpha-emmiting radionuclides for targeted alpha therapy

  • 11:22
Ver Detalles

Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography

  • 10:01
Ver Detalles

GMP-Compliant Automated Radiolabeling and Quality Controls of [68Ga]Ga-FAPI-46 for Fibroblast Activation Protein-Targeted PET Imaging in Clinical Settings

  • 11:41
Ver Detalles

Bismuth chelation for targeted alpha therapy: Current state of the art

  • 09:08
Ver Detalles

Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides

  • 09:07
Ver Detalles

Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?

  • 18:02
Ver Detalles

Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics

  • 12:07
Ver Detalles

Expanding Role for Gallium-68 PET Imaging in Oncology

  • 12:07
Ver Detalles

How nuclear imaging changed parathyroid surgical strategies through time

  • 10:09
Ver Detalles

Molecular Imaging in Gynecology: Beyond Cancer

  • 10:08
Ver Detalles

Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy

  • 10:02
Ver Detalles

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics

  • 10:53
Ver Detalles
La Radiofarmacia es la especialidad sanitaria que estudia los aspectos farmacéuticos, químicos, bioquímicos, biológicos y físicos de los radiofármacos.
  • Calle Velázquez,10 28001 Madrid
  • secretaria@serfaradiofarmacia.com
  • +34 910 601 760
© 2023 - Radiofarmacia - Sociedad Española de Radiofarmacia
Scroll al inicio